Although AOM liraglutide (Saxenda) has been approved for treatment of obesity in adolescents since late 2020 ( 5 ), the approval of AOM semaglutide (Wegovy) in December 2022 for treatment of obesity for adolescents prompted new excitement ( 6 )
Before starting any GLP-1 medication, patients should undergo thorough medical evaluations to ensure these drugs are appropriate for their health conditions
Perfect for those who want an all-in-one solution for anti-aging, brightening, and skin repair
Brand-name tirzepatide (Mounjaro for diabetes, Zepbound for weight loss) costs roughly $1,000 per month without insurance coverage
10.1002/ps.576 Pest Manag
However, this effect may be due to the large amount of cystine provided in the control conditions (208 M), as reduction of cystine levels in the medium did not impair growth but abolished intracellular cysteine and cystine levels (Extended Data Fig